Sharekhan has revised its rating for Atul Ltd., a leading specialty chemicals company, from “Hold” to “Buy,” setting an ambitious price target of Rs 8,294.
Morningstar has reiterated a ‘Buy’ rating for AstraZeneca (NASDAQ: AZN) with a fair value estimate of $78 per share, which represents a potential upside from the current market price of $65.19.
Motilal Oswal has reiterated a ‘Buy’ rating on Campus Activewear, setting a target price of Rs 360, which indicates a potential upside of 17% from the current price of Rs 307.
Motilal Oswal has maintained a ‘Buy’ recommendation for Hyundai Motor India (HMI), projecting a target price (TP) of Rs 2,235, a 24% upside from the current market price of Rs 1,804.
